Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

12.67
Delayed Data
As of May 31
 -0.30 / -2.31%
Today’s Change
6.51
Today|||52-Week Range
17.02
+27.98%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close12.97
Today’s open13.04
Day’s range12.39 - 13.06
Volume1,932,286
Average volume (3 months)1,091,600
Market cap$1.1B
Dividend yield--
Data as of 05/31/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-48.22%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+4.08%
P/E ratioNM
Price/Sales4.36
Price/Book8.54

Competitors

 Today’s
change
Today’s
% change
BABYNatus Medical Inc-0.37-1.13%
ABAXAbaxis Inc+0.17+0.37%
OMCLOmnicell Inc+0.60+1.87%
NVCRNovocure Ltd-0.17-1.50%
Data as of 05/31/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$153.6M
Annual profit (last year)-$50.4M
Net profit margin-32.83%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts

Partner Offers

Search for Jobs